Amyloid-β protein oligomerization and the importance of tetramers and dodecamers in the aetiology of Alzheimer's disease.
In recent years, small protein oligomers have been implicated in the aetiology of a number of important amyloid diseases, such as type 2 diabetes, Parkinson's disease and Alzheimer's disease. As a consequence, research efforts are being directed away from traditional targets, such as amylo...
Main Authors: | Bernstein, S, Dupuis, N, Lazo, N, Wyttenbach, T, Condron, M, Bitan, G, Teplow, D, Shea, J, Ruotolo, B, Robinson, C, Bowers, M |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2009
|
Similar Items
-
Modeling amyloid-beta as homogeneous dodecamers and in complex with cellular prion protein.
by: Steven L Gallion
Published: (2012-01-01) -
Photocontrolled reversible self-assembly of dodecamer nitrilase
by: Qiao Yu, et al.
Published: (2017-08-01) -
Blood amyloid-β oligomerization associated with neurodegeneration of Alzheimer’s disease
by: Young Chul Youn, et al.
Published: (2019-05-01) -
Microglial phagocytosis induced by fibrillar β-amyloid is attenuated by oligomeric β-amyloid: implications for Alzheimer's disease
by: Lin Nan, et al.
Published: (2011-06-01) -
Integration of amyloid-β oligomerization tendency as a plasma biomarker in Alzheimer's disease diagnosis
by: Jung-Min Pyun, et al.
Published: (2023-01-01)